Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery

2021 ◽  
Author(s):  
X. Li ◽  
J. Sanz ◽  
P. Foro ◽  
A. Martínez ◽  
M. Zhao ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Conservative Surgery ◽  
Long Term Results ◽  
Whole Breast Irradiation ◽  
Breast Irradiation ◽  
Breast Cancer Patients ◽  
Risk Breast Cancer

A Comparison of Complication Rates in Early-Stage Breast Cancer Patients Treated with Brachytherapy Versus Whole-Breast Irradiation

2014 ◽  
Vol 22 (4) ◽  
pp. 1140-1145 ◽  
Author(s):  
Nicolas Ajkay ◽  
Abigail E. Collett ◽  
Erica V. Bloomquist ◽  
Edward J. Gracely ◽  
Thomas G. Frazier ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Stage ◽  
Early Stage Breast Cancer ◽  
Complication Rates ◽  
Whole Breast Irradiation ◽  
Breast Irradiation ◽  
Breast Cancer Patients

Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

2005 ◽  
Vol 23 (9) ◽  
pp. 1934-1940 ◽  
Author(s):  
Jennifer R. Bellon ◽  
Steven E. Come ◽  
Rebecca S. Gelman ◽  
I. Craig Henderson ◽  
Lawrence N. Shulman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Statistical Power ◽  
Early Stage ◽  
Conservative Surgery ◽  
Early Stage Breast Cancer ◽  
Prospective Randomized Trial ◽  
Long Term Results ◽  
Breast Cancer Patients

Purpose The optimal integration of chemotherapy with radiation (RT) for patients with early-stage breast cancer remains uncertain. We present the long-term results of a prospective randomized trial to address this question. Patients and Methods Two hundred forty-four patients were randomly assigned after conservative breast surgery to receive 12 weeks of cyclophosphamide, doxorubicin, methotrexate, fluorouracil, and prednisone (CAMFP) before RT (CT-first) or after RT (RT-first). Median follow-up for surviving patients was 135 months. Results There were no significant differences between the CT-first and RT-first arms in time to any event, distant metastasis, or death. Sites of first failure were also not significantly different. Conclusion Among breast cancer patients treated with conservative surgery, there is no advantage to giving RT before adjuvant chemotherapy. However, this study does not have enough statistical power to rule out a clinically important survival benefit for either sequence.

OC-0334 Partial vs whole-breast irradiation for breast cancer patients in the randomized DBCG PBI trial

2021 ◽  
Vol 161 ◽  
pp. S247
Author(s):  
B. Offersen ◽  
J. Alsner ◽  
H.M. Nielsen ◽  
E.H. Jacobsen ◽  
M.H. Nielsen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Whole Breast Irradiation ◽  
Breast Irradiation ◽  
Breast Cancer Patients

Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients

Brachytherapy ◽  
2010 ◽  
Vol 9 (2) ◽  
pp. 171-177 ◽  
Author(s):  
Richard B. Wilder ◽  
Lisa D. Curcio ◽  
Rajesh K. Khanijou ◽  
Martin E. Eisner ◽  
Jane L. Kakkis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Accelerated Partial Breast Irradiation ◽  
Partial Breast Irradiation ◽  
Breast Irradiation ◽  
Breast Cancer Patients ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document